The emerging treatment of the medication represents a significant advance in the management of the condition. Different to existing drugs, tirzepatide affects two pathways – the GLP-1 hormone and GIP – resulting in https://tirzepatidepeptide082913.blue-blogs.com/50278102/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment